Vontobel Holding’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-43,795
Closed -$1.17M – 1068
2022
Q1
$1.17M Buy
43,795
+73
+0.2% +$2.07K 0.01% 575
2021
Q4
$1.77M Buy
43,722
+5,293
+14% +$241K 0.01% 476
2021
Q3
$1.92M Buy
38,429
+1,317
+4% +$71.8K 0.02% 448
2021
Q2
$2.08M Buy
37,112
+95
+0.3% +$5.06K 0.02% 427
2021
Q1
$1.73M Buy
37,017
+15,557
+72% +$754K 0.01% 430
2020
Q4
$1.15M Buy
+21,460
New +$792K 0.01% 510

Other funds holding HCAT

Vontobel Holding's HCAT Position: Q2 2022 in Review

Vontobel Holding sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 43,795 shares — an estimated $1.17M sold.

Vontobel Holding first reported a position in HCAT in Q4 2020 and held it in 6 quarters. The position peaked at $2.08M in Q2 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

  • Vontobel Holding reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
  • Vontobel Holding sold 43,795 Health Catalyst shares in Q2 2022, an estimated $1.17M.
  • Vontobel Holding first reported a position in Health Catalyst in Q4 2020 and held it in 6 quarters.
  • Vontobel Holding's Health Catalyst position peaked at $2.08M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Vontobel Holding's 13F filing for Q2 2022, filed 27 Jul 2022.